Clinical Profile and Therapy of Hepatocelluar Carcinoma at a Tertiary Care Institute from South India: A Retrospective Study of 182 Patients
Journal Title: Indian Journal of Cancer Education and Research - Year 2017, Vol 5, Issue 1
Abstract
Objective: To study the clinical profile and therapy of hepatocellular carcinoma (HCC) at a tertiary care institute in Andhrapradesh, Southindia. Methods: Data analysis of HCC patients enrolled in between 2000 and 2015. HCC was diagnosed according to EASL criteria-USG/CT/MRI of the abdomen and/or serum alpha-fetoprotein and/or histology (where indicated). Barcelona Clinic Liver Cancer (BCLC) staging was done. Results: We registered 182 HCC patients [males 162 (89%), mean age 57.5 ± 12.1 years]. An “Early Peak” (17%) was detected in 28-40 yr age group. The etiology of HCC was: Hepatitis B virus 70 (35.7%), Hepatitis C virus 05 (2.74%). Serum -fetoprotein was >500 ng/ml in 43.8% and very high (>5000-100 000) in 30.6%. Classical features on triple phase CT in 80% with an average tumor size of (7.3 ± 2.1 cm), Portal vein invasion was seen in 40% and distant metastases in 11%. Majority of the patients (79.6%) were BCLC stage C and D. Biochemical: Thrombocytopenia (60%), anaemia in 30%, and 80% had an elevated alkaline phosphatase levels. Therapy was offered to 127 (69.78%) patients.Treatment given was as follows: Surgical resection (n=36 19.78%); Chemotherapy, both oral and iv (n=91 19.78%), and Sorafenib (n=36 19.78%), Best supportive care (n=55 30.22%), but survival data was not available due to lack of adequate followup. Conclusions: Hepatitis B infection is the predominant cause for HCC. Diagnostic range serum -fetoprotein was detected in only 43.8% of study patients but its level correlates well with the disease burden, outcome. An “Early Peak” was observed in 28-40 year age group. Majority of the patients present with advanced disease, precluding the curative therapies. Universal immunization with hepatitis B vaccination will reduce the HBV infection rates & in part HCC burden in near future.
Authors and Affiliations
Venkatesh M.
Keywords
Related Articles
- EP ID EP459821
- DOI 10.21088/ijcer.2321.9815.5117.5
- Views 100
- Downloads 0
A Case Study on Lung Cancer: Proceedings of 3rd International Meeting of Clinical Practice Guidelines in Oncology
Third International Meeting of Clinical Practice Guidelines in Oncology–2014 and Indian Perspectives was conducted on December 20th 2014. The conference was organized by the unit of medical oncology, Sri Ramachandra Univ...
Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India
Background: Acute myeloid leukemia is a heterogenous clonal disorder of hematopoietic progenitor cells with different molecular genetic abnormalities, clinical characteristics and variable outcomes with currently availab...
Speciation and Resistotyping of Coagulase Negative Staphylococci in Clinical Isolates in Kerala Medical College, Palakkad
Introduction: Coagulase negative staphylococci are important causative agents of 10% of pyogenic infections in hospitals, which include a range of infections like surgical wound sepsis, bacteremia, native valve endocardi...
Chemotherapy For Bulky and Fixed Nodal Metastasis in Carcinoma Penis: A Case Report and Review of Literature
Penile cancer is an aggressive disease and in patients with advanced or metastatic disease, it is virtually incurable. While this squamous cell cancer responds to chemotherapy, successful treatment of lymphatic metastase...
Unraveling the Molecular Diversity of Lipid Degrading Enzymes from Microbial Consortia of a Cold Desert from India
Metagenomics has emerged as one of the important tools that can endow bottomless insights about the molecular diversity, distribution, ecological roles, microbial grouping and fastidious biological functions of microorga...